# UNIVERSAL HEALTH SERVICES INC (UHS) — capital_raise [announced]
Source: SEC API (secapi.ai) · situation sit_586c5081a54b455e33cd · retrieved 2026-08-11T15:48:45.500Z

## Overview
Universal Health Services, Inc. operates a network of general medical and surgical hospitals and behavioral health facilities.

Universal Health Services, Inc. entered into a Twelfth Amendment to its Credit Agreement on July 20, 2026, adding a new incremental delayed draw tranche A term loan facility of up to $700 million. The facility is available for drawdown from July 20, 2026 through September 30, 2026, and will mature 364 days after the date of funding. The loan does not amortize, with all outstanding amounts payable in full at maturity. The applicable margin is initially 0.125% for ABR Loans and 1.125% for Term Benchmark Loans and RFR Loans, based on the Company's Consolidated Net Leverage Ratio. The Company intends to use proceeds for general corporate purposes, including refinancing existing indebtedness and paying related fees and expenses.

## Terms
- Counterparty: JPMorgan Chase Bank, N.A., Bank of America, N.A., Truist Bank, U.S. Bank National Association, Wells Fargo Bank, National Association and other lenders · Deal value: $700.0M

## Key dates
- Announced 2026-07-21 · Expiry 2026-09-30

## Timeline
- 2026-07-21 · 8-K (0001193125-26-310330): 8-K - UNIVERSAL HEALTH SERVICES INC — *Universal Health Services, Inc. operates a network of general medical and surgical hospitals and behavioral health facilities.* Universal Health Services, Inc. entered into a Twelfth Amendment to its Credit Agreement on July 20, 2026, adding a new incremental delayed draw tranche A term loan facility of up to $700 million. The facility is available for drawdown from July 20, 2026 through September 30, 2026, and will mature 364 days after the date of funding. The loan does not amortize, with all outstanding amounts payable in full at maturity. The applicable margin is initially 0.125% for ABR Loans and 1.125% for Term Benchmark Loans and RFR Loans, based on the Company's Consolidated Net Leverage Ratio. The Company intends to use proceeds for general corporate purposes, including refinancing existing indebtedness and paying related fees and expenses.
  https://www.sec.gov/Archives/edgar/data/352915/0001193125-26-310330.txt

## Citations
- 0001193125-26-310330 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000119312526310330